Liver Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Aug 15, 2002; 8(4): 638-643
Published online Aug 15, 2002. doi: 10.3748/wjg.v8.i4.638
Table 1 Clinical profiles of patients with HCC: Comparison with p28 mRNA expression
VariablesnmRNA levelaDfp-valueb
Age (years)620.231
< 40182.910 ± 0.695
40-60352.790 ± 0.367
> 60111.673 ± 0.546
Sex620.401
Male582.734 ± 0.422
Female62.650 ± 0.238
HBsAg620.269
Positive452.919 ± 0.426
Negative192.317 ± 0.362
Cirrhosis620.180
Absent173.157 ± 0.885
Present472.631 ± 0.301
Table 2 Clinicopathological features of patients with HCC: Comparison with p28 mRNA expression
VariablesnmRNA levelaDfp-valueb
Serum AFP (ng/mL)620.330
< 25142.439 ± 0.362
25-1000212.469 ± 0.273
> 1000292.821 ± 0.389
Tumor size (cm)620.124
< 5212.393 ± 0.206
5-10272.852 ± 0.468
> 10163.001 ± 0.652
Capsule formation620.242
Positive462.661 ± 0.421
Negative183.016 ± 0.460
Fibrous capsular infiltration440.240
Positive212.833 ± 0.636
Negative252.513 ± 0.226
Hepatic vein involvement620.047
Positive193.726 ± 0.306
Negative452.442 ± 0.532
Satellite nodules620.243
Absent322.467 ± 0.209
Present322.931 ± 0.554
Portal vein thrombus620.021
Absent462.390 ± 0.230
Present183.971 ± 0.384
Histological gradec620.466
I-II202.809 ± 0.538
III-IV442.859 ± 0.655